Search News
| 172.08 Delayed Data As of Sep 21 |  -0.09 / -0.05%Today’s Change | 146.68 Today|||52-Week Range 190.36 | +7.88% Year-to-Date |
| Previous close | 172.17 |
| Today’s open | 172.57 |
| Day’s range | 171.79 - 173.94 |
| Volume | 886,011 |
| Average volume (3 months) | 720,204 |
| Market cap | $17.5B |
| Earnings growth (last year) | +73.93% |
| Earnings growth (this year) | +20.01% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +8.29% |
| P/E ratio | 13.6 |
| Price/Sales | 1.59 |
| Price/Book | 2.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| DGXQuest Diagnostics In... | -0.32 | -0.30% |
| GHDXGenomic Health Inc | +0.73 | +1.07% |
| NTRANatera Inc | +0.07 | +0.29% |
| NEONeogenomics Inc | -0.31 | -2.14% |
| Next reporting date | October 30, 2018 |
| EPS forecast (this quarter) | $2.88 |
| Annual revenue (last year) | $10.4B |
| Annual profit (last year) | $1.3B |
| Net profit margin | 12.15% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman, President & Chief Executive Officer David P. King |
Chief Financial Officer, Treasurer & Executive VP Glenn Andrew Eisenberg |
Corporate headquarters Burlington, North Carolina |
